Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment.
Saved in:
| Title: | Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment. |
|---|---|
| Authors: | Aguareles, Jose1,2,3 (AUTHOR), Villares Fernández, Paula4 (AUTHOR), Forné, Carles5,6 (AUTHOR), Martí-Ballesteros, Eva María2,7 (AUTHOR), Pradillo Fernández, Virginia2,7 (AUTHOR), Sotres-Fernandez, Gabriel1,2 (AUTHOR), de la Fuente-Burguera, Adolfo8 (AUTHOR), Navarro-San Francisco, Carolina9 (AUTHOR), Buzón-Martín, Luis Miguel9 (AUTHOR), García-Delangue, Teresa10 (AUTHOR), Aiello, Francesco Tommaso11 (AUTHOR), Carnevali-Ruiz, Daniel1,2 (AUTHOR), Lloris, Raquel12 (AUTHOR), Luepke-Estefan, Xavier Erik13 (AUTHOR), López-Martín, José Antonio12 (AUTHOR), Jimeno, José María12 (AUTHOR), García-Casas, Ana1,3 (AUTHOR), Guisado-Vasco, Pablo1,2 (AUTHOR) pablo.guisado@quironsalud.es |
| Source: | Infectious Diseases. Jul2024, Vol. 56 Issue 7, p575-580. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23744235 |
|---|---|
| DOI: | 10.1080/23744235.2024.2351043 |
